Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Final Impact of Anti-Vascular Endothelial Growth Factor Treatment in Age-related Macular Degeneration.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2018;59(11):1039-1048. Published online November 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.11.1039
Crossref 4; PDF

A Comparison of Efficacies of Aflibercept and Ranibizumab, Depending on the Angiographic Classification of Polypoidal Choroidal Vasculopathy.: Gahyung Ryu, Donghyoun Noh, Junyeop Lee, Min Sagong; J Korean Ophthalmol Soc. 2017;58(12):1356-1366. Published online December 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.12.1356; PDF

Efficacy of Primary Intravitreal Ranibizumab Injection for Treatment of Type 1 Retinopathy of Prematurity.: Gyu Chul Chung, Sung Hyuk Moon; J Korean Ophthalmol Soc. 2017;58(9):1080-1086. Published online September 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.9.1080
Crossref 2; PDF

Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome.: Jae Wook Han, Jong Woo Kim, Chul Gu Kim et al.; J Korean Ophthalmol Soc. 2017;58(9):1042-1049. Published online September 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.9.1042
Crossref 3; PDF

Case Reports

Intravitreal Ranibizumab Injection in Adult-onset Coats' Disease: A Case Report.: Han Ul Kim, Seong Hwan Shin, Sung Pyo Park; J Korean Ophthalmol Soc. 2017;58(7):870-874. Published online July 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.7.870; PDF

Original Articles

Comparison of Choroidal Thickness Change between Ranibizumab and Aflibercept in Age-related Macular Degeneration: Six Month Results.: Im Gyu Kim, Yong Il Kim, Jin Seon Kim, Jung Ho Lee, Kyoo Won Lee, Hyun Gu Kang; J Korean Ophthalmol Soc. 2017;58(3):296-304. Published online March 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.3.296
Crossref 5; PDF

Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab.: Kyung Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee; J Korean Ophthalmol Soc. 2017;58(1):62-68. Published online January 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.1.62
Crossref 4; PDF

Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients.: Ji Sang Min, Hyun Chul Jung, Ji Young Suh, Yoon Hyung Kwon; J Korean Ophthalmol Soc. 2016;57(11):1738-1744. Published online November 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.11.1738
Crossref 6; PDF

Long-term Outcomes of Diabetic Macular Edema Following Initial Intravitreal Ranibizumab Injection Based on Morphologic Pattern.: Kiyoung Kim, Eung Suk Kim, Hyung Woo Kwak, Seung Young Yu; J Korean Ophthalmol Soc. 2016;57(10):1604-1612. Published online October 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.10.1604
Crossref 8; PDF

Effects of Intravitreal Injection of Bevacizumab or Ranibizumab on Systemic Circulation.: Myung Hun Yoon, Young Jun Kim, So Young Lee, Kang Won Lee, Hee Seung Chin; J Korean Ophthalmol Soc. 2016;57(3):429-437. Published online March 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.3.429
Crossref 5; PDF

Comparison of Short-Term Clinical Outcomes between Intravitreal Ranibizumab and Aflibercept in Retinal Angiomatous Proliferation.: Oh Jae Kim, Jae Hui Kim, Jong Woo Kim et al.; J Korean Ophthalmol Soc. 2016;57(2):243-247. Published online February 1, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.2.243
Crossref 5; PDF

Correlation between Visual Outcomes and Pre-Treatment Factors Including Hyperreflective Foci in Neovascular Age-Related Macular Degeneration.: Hyung Woo Lee, Hyung Chan Kim; J Korean Ophthalmol Soc. 2015;56(8):1188-1194. Published online August 15, 2015; DOI: https://doi.org/10.3341/jkos.2015.56.8.1188
Crossref 4; PDF

Comparison of Choroidal Hyperpermeability Change after Photodynamic Therapy and Ranibizumab for Chronic Central Serous Chorioretinopathy.: Jeong Ah Kim, Joo Young Shin, So Hyun Bae, Jee Yun Ahn, Hum Chung, Jang Won Heo; J Korean Ophthalmol Soc. 2015;56(2):205-212. Published online February 15, 2015; DOI: https://doi.org/10.3341/jkos.2015.56.2.205
Crossref 2; PDF

Effect of Bevacizumab and Ranibizumab on the Expression of eNOS in Trabecular Meshwork Cells.: Se Eun Kim, Jae Woo Kim; J Korean Ophthalmol Soc. 2014;55(8):1208-1212. Published online August 15, 2014; DOI: https://doi.org/10.3341/jkos.2014.55.8.1208; PDF

Risk Factors for Retinal Pigment Epithelium Tears after Anti-VEGF Agent Injection in Age-Related Macular Degeneration.: Woo Seok Choae, Jae Hong Park, Woo Seok Lee, Sang Won Kim, Hee Seong Yoon; J Korean Ophthalmol Soc. 2013;54(10):1546-1553. Published online October 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.10.1546
Crossref 2; PDF

Volume 65, No. 4

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

4,789	Contact Lens-induced Acute Red Eye
6,236	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
2,961	Two Cases of Cataract after COVID-19 mRNA Vaccine Injection
1,938	Clinical Outcomes of ATOS-mediated SmartSight Lenticule Extraction
4,082	Clinical Benefits of Amniotic Membrane Contact Lens

Cited By 3	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
Cited By 2	Comparison of Anterior Segment Measurements between Scheimpflug-Placido Camera and New Swept-source Optical Coherence Tomography
Cited By 2	Interocular Difference of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Astigmatism According to Axial Length
Cited By 2	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
Cited By 2	Clinical Benefits of Amniotic Membrane Contact Lens

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2024 by Korean Ophthalmological Society.

prev

next